EmVenio Insights

Explore our resources, including blogs, whitepapers, press, videos, and more.

 

World Vaccine Congress 2023

EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in…

EmVenio Research March 2023 Community Engagement Overview

EmVenio Research’s dedication to the community is demonstrated by action. Our passion for engaging local communities is what sets us apart. On March 6th, our mobile Community Research Site was on campus! The students from Georgia Tech School of Industrial…

EmVenio Research names new chief medical officer

DURHAM, N.C., April 11, 2023 /PRNewswire/ — EmVenio Research today announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiatives in the clinical and therapeutic areas. He will also provide medical…

EmVenio featured in CenterWatch

EmVenio president Thad Wolfram spoke to CenterWatch about our innovative approach to expand access and diversity in clinical trials through our fleet of mobile community research sites. Thad discussed how EmVenio was formed and its mission behind the work we…

Activated Sites

EmVenio Research is committed to helping you achieve your DEI objectives and meet enrollment goals. With our 10 active Community Research Sites located in geographies providing access to underserved and difficult to reach populations, we enable you to enroll the…

SCOPE Summit 2023

The SCOPE 2023 Summit was a major success, with attendees from all over the world gathering to learn more about the latest developments in the clinical trial industry. The event was full of memorable moments, from keynotes, workshops, and demos…